Outcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS—A Study of the CMWP of the EBMT

Patients ≥18 years with chronic myelomonocytic leukemia and myelodysplastic syndromes undergoing hematopoietic cell transplantation reported to the EBMT registry were analyzed.